These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 32457390)
1. Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure. Zhao K; Li Y; Liu Z; Long H; Zhao C; Luo F; Sun Y; Tao Y; Su XD; Li D; Li X; Liu C Nat Commun; 2020 May; 11(1):2643. PubMed ID: 32457390 [TBL] [Abstract][Full Text] [Related]
2. Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding. Long H; Zheng W; Liu Y; Sun Y; Zhao K; Liu Z; Xia W; Lv S; Liu Z; Li D; He KW; Liu C Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972418 [TBL] [Abstract][Full Text] [Related]
3. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316 [TBL] [Abstract][Full Text] [Related]
4. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure. Boyer DR; Li B; Sun C; Fan W; Zhou K; Hughes MP; Sawaya MR; Jiang L; Eisenberg DS Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3592-3602. PubMed ID: 32015135 [TBL] [Abstract][Full Text] [Related]
5. Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K. Lemkau LR; Comellas G; Lee SW; Rikardsen LK; Woods WS; George JM; Rienstra CM PLoS One; 2013; 8(3):e49750. PubMed ID: 23505409 [TBL] [Abstract][Full Text] [Related]
7. The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein. Sun Y; Long H; Xia W; Wang K; Zhang X; Sun B; Cao Q; Zhang Y; Dai B; Li D; Liu C Nat Commun; 2021 Oct; 12(1):6252. PubMed ID: 34716315 [TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface. Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760 [TBL] [Abstract][Full Text] [Related]
9. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160 [TBL] [Abstract][Full Text] [Related]
11. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation. Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596 [TBL] [Abstract][Full Text] [Related]
12. Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy. Flynn JD; McGlinchey RP; Walker RL; Lee JC J Biol Chem; 2018 Jan; 293(3):767-776. PubMed ID: 29191831 [TBL] [Abstract][Full Text] [Related]
13. Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein. Wise-Scira O; Dunn A; Aloglu AK; Sakallioglu IT; Coskuner O ACS Chem Neurosci; 2013 Mar; 4(3):498-508. PubMed ID: 23374074 [TBL] [Abstract][Full Text] [Related]
14. Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations. Ni X; McGlinchey RP; Jiang J; Lee JC J Mol Biol; 2019 Sep; 431(19):3913-3919. PubMed ID: 31295458 [TBL] [Abstract][Full Text] [Related]
15. Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils. Liu K; Tao Y; Zhao Q; Xia W; Li X; Zhang S; Yao Y; Xiang H; Han C; Tan L; Sun B; Li D; Li A; Liu C Proc Natl Acad Sci U S A; 2024 Aug; 121(35):e2321633121. PubMed ID: 39172784 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence. Kang L; Janowska MK; Moriarty GM; Baum J PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates. Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N Biochem Biophys Res Commun; 2019 Jan; 508(3):729-734. PubMed ID: 30528390 [TBL] [Abstract][Full Text] [Related]
18. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283 [TBL] [Abstract][Full Text] [Related]
19. The effect of amino acid substitution in the imperfect repeat sequences of alpha-synuclein on fibrillation. Harada R; Kobayashi N; Kim J; Nakamura C; Han SW; Ikebukuro K; Sode K Biochim Biophys Acta; 2009 Oct; 1792(10):998-1003. PubMed ID: 19596443 [TBL] [Abstract][Full Text] [Related]
20. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]